Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
van Luin
Matthijs
M
Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. m.vanluin@akf.umcn.nl
Van der Ende
Marchina E
ME
Richter
Clemens
C
Visser
Mirjam
M
Faraj
Diari
D
Van der Ven
Andre
A
Gelinck
Luc
L
Kroon
Frank
F
Wit
Ferdinand W
FW
Van Schaik
Ron H N
RH
Kuks
Paul F M
PF
Burger
David M
DM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000480:Alkynes; D000069446:Atazanavir Sulfate; D053626:Atovaquone / Q000097:blood*; D048588:Benzoxazines / Q000008:administration & dosage / Q000493:pharmacokinetics; D003521:Cyclopropanes; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000493:pharmacokinetics; D002727:Proguanil / Q000097:blood*; D011725:Pyridines / Q000008:administration & dosage / Q000493:pharmacokinetics; D011744:Pyrimidinones / Q000008:administration & dosage / Q000493:pharmacokinetics; D019438:Ritonavir / Q000008:administration & dosage / Q000493:pharmacokinetics; D055815:Young Adult
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D011744:Pyrimidinones; D061466:Lopinavir; D000069446:Atazanavir Sulfate; C098320:efavirenz; D019438:Ritonavir; D002727:Proguanil; D053626:Atovaquone